| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Testis | 120 | 2023 | 717 | 19.140 |
Why?
|
| Spermatogonia | 55 | 2023 | 155 | 8.170 |
Why?
|
| Spermatogenesis | 64 | 2023 | 308 | 7.720 |
Why?
|
| Spermatozoa | 34 | 2024 | 315 | 5.800 |
Why?
|
| Infertility, Male | 25 | 2024 | 297 | 4.370 |
Why?
|
| Cryopreservation | 18 | 2023 | 175 | 3.460 |
Why?
|
| Sertoli Cells | 30 | 2021 | 150 | 3.310 |
Why?
|
| Organ Culture Techniques | 11 | 2022 | 241 | 3.250 |
Why?
|
| Callithrix | 29 | 2021 | 45 | 2.950 |
Why?
|
| Germ Cells | 19 | 2022 | 335 | 2.680 |
Why?
|
| Seminiferous Tubules | 18 | 2020 | 52 | 2.430 |
Why?
|
| Fertility Preservation | 7 | 2022 | 150 | 2.210 |
Why?
|
| Fertility | 12 | 2023 | 336 | 2.130 |
Why?
|
| Macaca mulatta | 22 | 2016 | 717 | 2.050 |
Why?
|
| Spectrum Analysis, Raman | 5 | 2018 | 41 | 1.970 |
Why?
|
| Stem Cells | 16 | 2023 | 1213 | 1.920 |
Why?
|
| Sperm Motility | 6 | 2024 | 106 | 1.830 |
Why?
|
| Transplantation, Heterologous | 21 | 2019 | 1082 | 1.720 |
Why?
|
| Anti-Mullerian Hormone | 3 | 2021 | 61 | 1.540 |
Why?
|
| Adult Germline Stem Cells | 3 | 2020 | 8 | 1.470 |
Why?
|
| Semen Analysis | 5 | 2022 | 32 | 1.430 |
Why?
|
| Male | 183 | 2024 | 123000 | 1.350 |
Why?
|
| Animals | 156 | 2023 | 59536 | 1.330 |
Why?
|
| Follicle Stimulating Hormone | 23 | 2021 | 241 | 1.330 |
Why?
|
| Cell Differentiation | 29 | 2021 | 4078 | 1.320 |
Why?
|
| Testosterone | 30 | 2023 | 619 | 1.280 |
Why?
|
| Primates | 8 | 2023 | 128 | 1.150 |
Why?
|
| Gonadotropins | 2 | 2021 | 50 | 1.130 |
Why?
|
| Reproductive Medicine | 2 | 2020 | 50 | 1.120 |
Why?
|
| Semen | 5 | 2024 | 90 | 1.070 |
Why?
|
| Sexual Maturation | 11 | 2021 | 65 | 1.040 |
Why?
|
| Glial Cell Line-Derived Neurotrophic Factor Receptors | 5 | 2014 | 26 | 1.030 |
Why?
|
| Inhibins | 10 | 2021 | 128 | 1.020 |
Why?
|
| Ultraviolet Rays | 2 | 2018 | 575 | 0.950 |
Why?
|
| Cell Separation | 5 | 2020 | 612 | 0.880 |
Why?
|
| Asthenozoospermia | 1 | 2022 | 8 | 0.870 |
Why?
|
| Morphogenesis | 7 | 2020 | 337 | 0.860 |
Why?
|
| Induced Pluripotent Stem Cells | 2 | 2021 | 203 | 0.830 |
Why?
|
| Flow Cytometry | 12 | 2021 | 3033 | 0.830 |
Why?
|
| Kisspeptins | 3 | 2016 | 15 | 0.830 |
Why?
|
| Phodopus | 12 | 2010 | 12 | 0.830 |
Why?
|
| Culture Media, Serum-Free | 1 | 2021 | 74 | 0.830 |
Why?
|
| DNA Modification Methylases | 1 | 2022 | 172 | 0.800 |
Why?
|
| Staining and Labeling | 3 | 2021 | 429 | 0.780 |
Why?
|
| DNA Fragmentation | 1 | 2021 | 198 | 0.780 |
Why?
|
| Aging | 10 | 2021 | 1582 | 0.760 |
Why?
|
| DNA | 6 | 2022 | 2693 | 0.750 |
Why?
|
| Seminal Vesicles | 4 | 2015 | 152 | 0.750 |
Why?
|
| Toxicology | 1 | 2020 | 14 | 0.750 |
Why?
|
| Lab-On-A-Chip Devices | 1 | 2020 | 25 | 0.740 |
Why?
|
| Sex Differentiation | 1 | 2020 | 41 | 0.740 |
Why?
|
| Semen Preservation | 5 | 2011 | 17 | 0.730 |
Why?
|
| Microfluidic Analytical Techniques | 1 | 2020 | 44 | 0.720 |
Why?
|
| Meiosis | 8 | 2021 | 166 | 0.720 |
Why?
|
| Immunohistochemistry | 31 | 2020 | 7548 | 0.700 |
Why?
|
| Cells, Cultured | 22 | 2020 | 5637 | 0.700 |
Why?
|
| Abortion, Habitual | 1 | 2019 | 24 | 0.700 |
Why?
|
| Annexin A5 | 1 | 2019 | 72 | 0.690 |
Why?
|
| Sperm Count | 10 | 2022 | 100 | 0.690 |
Why?
|
| Blastocyst | 6 | 2022 | 124 | 0.690 |
Why?
|
| Temperature | 1 | 2020 | 506 | 0.690 |
Why?
|
| Macaca fascicularis | 18 | 2023 | 137 | 0.670 |
Why?
|
| Rats | 29 | 2020 | 6086 | 0.660 |
Why?
|
| Cricetinae | 17 | 2014 | 706 | 0.660 |
Why?
|
| Specimen Handling | 1 | 2020 | 299 | 0.650 |
Why?
|
| Mice | 54 | 2022 | 34495 | 0.650 |
Why?
|
| DNA Methylation | 5 | 2022 | 2669 | 0.630 |
Why?
|
| Cell Culture Techniques | 8 | 2016 | 598 | 0.630 |
Why?
|
| Embryo Culture Techniques | 5 | 2022 | 35 | 0.620 |
Why?
|
| Klinefelter Syndrome | 3 | 2019 | 23 | 0.610 |
Why?
|
| Spectrum Analysis | 1 | 2018 | 139 | 0.610 |
Why?
|
| DNA Damage | 4 | 2020 | 1954 | 0.600 |
Why?
|
| Ovary | 5 | 2017 | 668 | 0.580 |
Why?
|
| Water | 1 | 2018 | 361 | 0.570 |
Why?
|
| Plant Lectins | 1 | 2016 | 27 | 0.570 |
Why?
|
| Pluripotent Stem Cells | 4 | 2020 | 123 | 0.560 |
Why?
|
| Humans | 99 | 2024 | 261506 | 0.550 |
Why?
|
| Hypothalamo-Hypophyseal System | 1 | 2016 | 127 | 0.540 |
Why?
|
| Animals, Newborn | 13 | 2018 | 1338 | 0.540 |
Why?
|
| Reproductive Techniques, Assisted | 5 | 2023 | 101 | 0.540 |
Why?
|
| Graft Survival | 8 | 2017 | 1062 | 0.520 |
Why?
|
| Cell Nucleus | 3 | 2018 | 1620 | 0.520 |
Why?
|
| Photoperiod | 5 | 2007 | 31 | 0.500 |
Why?
|
| Mice, Nude | 16 | 2017 | 4307 | 0.500 |
Why?
|
| Blastomeres | 3 | 2019 | 24 | 0.500 |
Why?
|
| Sex Reassignment Surgery | 3 | 2021 | 14 | 0.500 |
Why?
|
| Single-Cell Analysis | 5 | 2021 | 470 | 0.490 |
Why?
|
| Stem Cell Transplantation | 5 | 2013 | 1360 | 0.490 |
Why?
|
| Cell Proliferation | 9 | 2021 | 7226 | 0.470 |
Why?
|
| Azoospermia | 4 | 2022 | 45 | 0.470 |
Why?
|
| Primary Cell Culture | 1 | 2014 | 208 | 0.470 |
Why?
|
| Immunomagnetic Separation | 3 | 2009 | 43 | 0.460 |
Why?
|
| Multiprotein Complexes | 1 | 2015 | 395 | 0.460 |
Why?
|
| Tissue Preservation | 3 | 2011 | 30 | 0.450 |
Why?
|
| Cell Communication | 4 | 2020 | 509 | 0.450 |
Why?
|
| Receptors, G-Protein-Coupled | 2 | 2016 | 488 | 0.450 |
Why?
|
| Insulin | 1 | 2019 | 1454 | 0.440 |
Why?
|
| Species Specificity | 8 | 2020 | 777 | 0.430 |
Why?
|
| Proteins | 3 | 2022 | 1963 | 0.430 |
Why?
|
| Organ Size | 14 | 2014 | 690 | 0.430 |
Why?
|
| Macaca | 6 | 2019 | 95 | 0.400 |
Why?
|
| Gonadal Steroid Hormones | 4 | 2017 | 110 | 0.400 |
Why?
|
| Principal Component Analysis | 4 | 2021 | 218 | 0.400 |
Why?
|
| Sirolimus | 1 | 2015 | 814 | 0.400 |
Why?
|
| Testicular Hormones | 1 | 2010 | 20 | 0.380 |
Why?
|
| Mitosis | 6 | 2017 | 615 | 0.370 |
Why?
|
| Bromodeoxyuridine | 8 | 2008 | 139 | 0.370 |
Why?
|
| Neoplasm Proteins | 2 | 2021 | 3230 | 0.370 |
Why?
|
| Models, Animal | 8 | 2013 | 664 | 0.370 |
Why?
|
| Transsexualism | 2 | 2021 | 15 | 0.360 |
Why?
|
| Pineal Gland | 4 | 1993 | 50 | 0.350 |
Why?
|
| Cleavage Stage, Ovum | 2 | 2019 | 11 | 0.350 |
Why?
|
| RNA, Messenger | 16 | 2022 | 6150 | 0.340 |
Why?
|
| Leydig Cells | 8 | 2013 | 39 | 0.340 |
Why?
|
| Circadian Rhythm | 4 | 2008 | 330 | 0.340 |
Why?
|
| TOR Serine-Threonine Kinases | 1 | 2015 | 1546 | 0.330 |
Why?
|
| Retinal Pigment Epithelium | 2 | 2019 | 37 | 0.330 |
Why?
|
| Embryo, Mammalian | 5 | 2019 | 741 | 0.330 |
Why?
|
| Receptor, trkA | 1 | 2008 | 35 | 0.330 |
Why?
|
| Animals, Wild | 2 | 2007 | 28 | 0.330 |
Why?
|
| Ovarian Follicle | 3 | 2017 | 152 | 0.320 |
Why?
|
| Reactive Oxygen Species | 1 | 2013 | 987 | 0.320 |
Why?
|
| Gonads | 3 | 2023 | 53 | 0.320 |
Why?
|
| Cell Count | 9 | 2022 | 508 | 0.320 |
Why?
|
| Embryonic Development | 3 | 2019 | 306 | 0.320 |
Why?
|
| Histocytological Preparation Techniques | 1 | 2008 | 17 | 0.320 |
Why?
|
| Transgender Persons | 2 | 2021 | 55 | 0.320 |
Why?
|
| Culture Media | 4 | 2022 | 319 | 0.310 |
Why?
|
| Retina | 3 | 2019 | 532 | 0.310 |
Why?
|
| Gene Expression | 8 | 2021 | 3570 | 0.310 |
Why?
|
| Body Weight | 12 | 2013 | 1293 | 0.310 |
Why?
|
| Luteinizing Hormone | 8 | 2021 | 165 | 0.310 |
Why?
|
| Biomarkers | 17 | 2021 | 5047 | 0.300 |
Why?
|
| Extinction, Biological | 1 | 2007 | 2 | 0.300 |
Why?
|
| Animals, Domestic | 1 | 2007 | 40 | 0.300 |
Why?
|
| DEAD-box RNA Helicases | 3 | 2018 | 255 | 0.290 |
Why?
|
| Androgens | 4 | 2004 | 511 | 0.290 |
Why?
|
| Fertilization in Vitro | 4 | 2024 | 199 | 0.280 |
Why?
|
| Chemokine CXCL12 | 3 | 2017 | 132 | 0.280 |
Why?
|
| Gene Expression Regulation, Developmental | 5 | 2018 | 1498 | 0.280 |
Why?
|
| Cats | 3 | 2018 | 166 | 0.280 |
Why?
|
| Spermatids | 4 | 2019 | 42 | 0.280 |
Why?
|
| Indole Alkaloids | 2 | 2020 | 7 | 0.270 |
Why?
|
| Oligospermia | 4 | 2011 | 67 | 0.270 |
Why?
|
| X-Rays | 2 | 2007 | 146 | 0.270 |
Why?
|
| Models, Theoretical | 1 | 2010 | 785 | 0.270 |
Why?
|
| Adult | 20 | 2023 | 77950 | 0.270 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2019 | 5539 | 0.270 |
Why?
|
| Embryo Transfer | 4 | 2015 | 83 | 0.260 |
Why?
|
| Cell Lineage | 4 | 2022 | 668 | 0.260 |
Why?
|
| Receptors, CXCR | 2 | 2015 | 19 | 0.260 |
Why?
|
| Carbazoles | 2 | 2020 | 87 | 0.260 |
Why?
|
| Signal Transduction | 7 | 2020 | 11965 | 0.260 |
Why?
|
| RNA-Binding Proteins | 4 | 2021 | 984 | 0.250 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2020 | 4757 | 0.250 |
Why?
|
| Radiation Injuries, Experimental | 2 | 2007 | 82 | 0.250 |
Why?
|
| Time Factors | 12 | 2020 | 12926 | 0.250 |
Why?
|
| Proto-Oncogene Proteins c-kit | 4 | 2005 | 479 | 0.250 |
Why?
|
| Seasons | 3 | 2008 | 340 | 0.240 |
Why?
|
| Retinal Ganglion Cells | 3 | 2018 | 144 | 0.240 |
Why?
|
| Coculture Techniques | 2 | 2020 | 626 | 0.240 |
Why?
|
| Melatonin | 3 | 1993 | 46 | 0.240 |
Why?
|
| Seeds | 1 | 2023 | 42 | 0.230 |
Why?
|
| Models, Biological | 3 | 2016 | 3254 | 0.230 |
Why?
|
| Molting | 1 | 2003 | 7 | 0.230 |
Why?
|
| Reproduction | 3 | 2011 | 253 | 0.230 |
Why?
|
| Stem Cell Factor | 3 | 1997 | 87 | 0.230 |
Why?
|
| Antineoplastic Agents | 5 | 2019 | 14289 | 0.230 |
Why?
|
| Nerve Regeneration | 2 | 2018 | 105 | 0.220 |
Why?
|
| Gonadotropin-Releasing Hormone | 5 | 2014 | 167 | 0.220 |
Why?
|
| Uterus | 5 | 2011 | 678 | 0.220 |
Why?
|
| Bone Marrow Diseases | 1 | 2024 | 177 | 0.220 |
Why?
|
| Pituitary Gland | 4 | 2013 | 150 | 0.220 |
Why?
|
| Dihydrotestosterone | 2 | 2021 | 118 | 0.210 |
Why?
|
| Choristoma | 2 | 2017 | 85 | 0.210 |
Why?
|
| Nanog Homeobox Protein | 1 | 2022 | 65 | 0.210 |
Why?
|
| Positive Regulatory Domain I-Binding Factor 1 | 1 | 2021 | 17 | 0.210 |
Why?
|
| Antigens, Surface | 3 | 2009 | 295 | 0.210 |
Why?
|
| Cell Compartmentation | 1 | 2021 | 76 | 0.200 |
Why?
|
| Tandem Mass Spectrometry | 2 | 2021 | 368 | 0.200 |
Why?
|
| Chorionic Gonadotropin | 6 | 2013 | 130 | 0.200 |
Why?
|
| Spermatocytes | 5 | 2007 | 43 | 0.190 |
Why?
|
| Oxidative Stress | 4 | 2019 | 1129 | 0.190 |
Why?
|
| Puberty | 2 | 2011 | 104 | 0.190 |
Why?
|
| Ejaculation | 1 | 2020 | 24 | 0.190 |
Why?
|
| Cell Division | 5 | 1999 | 2489 | 0.190 |
Why?
|
| Proliferating Cell Nuclear Antigen | 3 | 1999 | 195 | 0.190 |
Why?
|
| Healthy Aging | 1 | 2020 | 9 | 0.190 |
Why?
|
| Orchiectomy | 4 | 2010 | 214 | 0.190 |
Why?
|
| Axons | 2 | 2018 | 403 | 0.190 |
Why?
|
| Receptor, Fibroblast Growth Factor, Type 3 | 2 | 2018 | 62 | 0.190 |
Why?
|
| Granulocyte-Macrophage Colony-Stimulating Factor | 1 | 2022 | 408 | 0.190 |
Why?
|
| Twinning, Monozygotic | 1 | 2019 | 3 | 0.180 |
Why?
|
| Microscopy, Electron, Scanning | 1 | 2020 | 220 | 0.180 |
Why?
|
| Nerve Tissue Proteins | 3 | 2017 | 1491 | 0.180 |
Why?
|
| Organic Cation Transporter 2 | 1 | 2019 | 5 | 0.180 |
Why?
|
| Prostatic Secretory Proteins | 1 | 1999 | 6 | 0.180 |
Why?
|
| Octamer Transcription Factor-1 | 1 | 2019 | 10 | 0.180 |
Why?
|
| Receptors, Peptide | 1 | 2020 | 86 | 0.180 |
Why?
|
| beta-Synuclein | 1 | 2019 | 3 | 0.180 |
Why?
|
| Actins | 4 | 2017 | 608 | 0.180 |
Why?
|
| Stem Cell Niche | 1 | 2020 | 94 | 0.170 |
Why?
|
| alpha-Glucosidases | 1 | 2019 | 55 | 0.170 |
Why?
|
| Chemokine CXCL11 | 2 | 2017 | 11 | 0.170 |
Why?
|
| Hair Color | 2 | 2003 | 20 | 0.170 |
Why?
|
| Gene Editing | 1 | 2021 | 216 | 0.170 |
Why?
|
| Cold Temperature | 3 | 2011 | 121 | 0.170 |
Why?
|
| Prolactin | 1 | 2019 | 155 | 0.170 |
Why?
|
| Oocytes | 4 | 2017 | 414 | 0.170 |
Why?
|
| Reproducibility of Results | 6 | 2022 | 6009 | 0.170 |
Why?
|
| Seminiferous Epithelium | 3 | 2014 | 5 | 0.170 |
Why?
|
| Embryo Implantation | 3 | 2022 | 278 | 0.170 |
Why?
|
| Erectile Dysfunction | 1 | 2021 | 212 | 0.170 |
Why?
|
| Rats, Sprague-Dawley | 12 | 2013 | 2063 | 0.170 |
Why?
|
| Fructose | 1 | 2019 | 72 | 0.170 |
Why?
|
| Female | 37 | 2023 | 141928 | 0.160 |
Why?
|
| Receptors, Transforming Growth Factor beta | 1 | 2020 | 229 | 0.160 |
Why?
|
| Cisplatin | 2 | 2019 | 2432 | 0.160 |
Why?
|
| Genomic Imprinting | 1 | 2019 | 194 | 0.160 |
Why?
|
| Protamines | 1 | 2018 | 29 | 0.160 |
Why?
|
| snRNP Core Proteins | 1 | 2018 | 9 | 0.160 |
Why?
|
| CRISPR-Cas Systems | 1 | 2021 | 323 | 0.160 |
Why?
|
| Ovarian Reserve | 1 | 2017 | 10 | 0.160 |
Why?
|
| Age Factors | 7 | 2018 | 5377 | 0.160 |
Why?
|
| Estradiol | 6 | 2021 | 748 | 0.160 |
Why?
|
| Hypogonadism | 1 | 2021 | 257 | 0.150 |
Why?
|
| Ovulation Induction | 1 | 2017 | 62 | 0.150 |
Why?
|
| Pregnancy | 8 | 2022 | 7573 | 0.150 |
Why?
|
| Hypothalamic Hormones | 1 | 2016 | 8 | 0.150 |
Why?
|
| Peptide Elongation Factor 1 | 1 | 2017 | 28 | 0.150 |
Why?
|
| Hypothalamus | 2 | 2016 | 255 | 0.150 |
Why?
|
| Angiostatins | 1 | 2016 | 7 | 0.150 |
Why?
|
| Gene Conversion | 1 | 2016 | 19 | 0.150 |
Why?
|
| Mice, Inbred C57BL | 7 | 2018 | 6942 | 0.150 |
Why?
|
| Chromatin | 1 | 2022 | 942 | 0.150 |
Why?
|
| Haplotypes | 1 | 2019 | 856 | 0.150 |
Why?
|
| Cattle | 5 | 2017 | 783 | 0.150 |
Why?
|
| Macular Degeneration | 1 | 2018 | 114 | 0.140 |
Why?
|
| Equipment Design | 1 | 2020 | 1204 | 0.140 |
Why?
|
| Fovea Centralis | 1 | 2016 | 23 | 0.140 |
Why?
|
| Macrophages | 2 | 2002 | 1304 | 0.140 |
Why?
|
| Real-Time Polymerase Chain Reaction | 6 | 2019 | 1217 | 0.140 |
Why?
|
| Cell Survival | 2 | 2020 | 3045 | 0.140 |
Why?
|
| RNA | 1 | 2021 | 1013 | 0.140 |
Why?
|
| Thyroxine | 1 | 2016 | 116 | 0.140 |
Why?
|
| Muscle, Smooth | 2 | 1995 | 236 | 0.140 |
Why?
|
| Biopsy | 4 | 2018 | 3443 | 0.140 |
Why?
|
| Gender Dysphoria | 1 | 2015 | 5 | 0.140 |
Why?
|
| Promoter Regions, Genetic | 2 | 2019 | 3101 | 0.140 |
Why?
|
| Polymerase Chain Reaction | 4 | 2018 | 3203 | 0.140 |
Why?
|
| Thyroid Diseases | 1 | 2016 | 85 | 0.140 |
Why?
|
| Keratoconus | 1 | 2016 | 53 | 0.140 |
Why?
|
| Retinal Vessels | 1 | 2016 | 85 | 0.140 |
Why?
|
| Leukocytes | 2 | 2012 | 422 | 0.140 |
Why?
|
| Hydroxyindoleacetic Acid | 2 | 1993 | 25 | 0.140 |
Why?
|
| Endocrine Glands | 1 | 1995 | 19 | 0.140 |
Why?
|
| Protein Kinases | 1 | 2020 | 874 | 0.140 |
Why?
|
| Feedback, Physiological | 1 | 2016 | 193 | 0.130 |
Why?
|
| Enzyme Assays | 1 | 2015 | 22 | 0.130 |
Why?
|
| Seminoma | 2 | 2014 | 81 | 0.130 |
Why?
|
| Histocompatibility Antigens Class I | 1 | 2016 | 235 | 0.130 |
Why?
|
| Genes, X-Linked | 1 | 2015 | 66 | 0.130 |
Why?
|
| Genetic Heterogeneity | 1 | 2017 | 318 | 0.130 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 7 | 2014 | 3639 | 0.130 |
Why?
|
| Busulfan | 3 | 2014 | 764 | 0.130 |
Why?
|
| Clone Cells | 2 | 2006 | 555 | 0.130 |
Why?
|
| Receptor, PAR-2 | 1 | 2014 | 6 | 0.130 |
Why?
|
| Oogonia | 1 | 2014 | 1 | 0.130 |
Why?
|
| Aldehyde Dehydrogenase | 1 | 2014 | 103 | 0.120 |
Why?
|
| Mice, Transgenic | 3 | 2015 | 4143 | 0.120 |
Why?
|
| Mechanistic Target of Rapamycin Complex 1 | 1 | 2015 | 265 | 0.120 |
Why?
|
| Inflammation | 5 | 2018 | 2522 | 0.120 |
Why?
|
| Heterografts | 1 | 2017 | 733 | 0.120 |
Why?
|
| Proteome | 1 | 2018 | 561 | 0.120 |
Why?
|
| Sperm Injections, Intracytoplasmic | 2 | 2012 | 42 | 0.120 |
Why?
|
| Serotonin | 2 | 1993 | 264 | 0.120 |
Why?
|
| Apoptosis | 6 | 2019 | 7591 | 0.120 |
Why?
|
| Gene Expression Regulation | 5 | 2021 | 4053 | 0.120 |
Why?
|
| Mammals | 1 | 2015 | 361 | 0.120 |
Why?
|
| Estrus | 1 | 1993 | 19 | 0.120 |
Why?
|
| Europe | 1 | 2015 | 649 | 0.120 |
Why?
|
| Animal Testing Alternatives | 1 | 2013 | 3 | 0.120 |
Why?
|
| Embryonic Stem Cells | 2 | 2013 | 301 | 0.120 |
Why?
|
| Antispermatogenic Agents | 1 | 2013 | 2 | 0.120 |
Why?
|
| Pilot Projects | 1 | 2020 | 2803 | 0.120 |
Why?
|
| Norethindrone | 1 | 2013 | 16 | 0.120 |
Why?
|
| Epididymis | 5 | 2015 | 68 | 0.120 |
Why?
|
| Peptides | 1 | 1999 | 1479 | 0.110 |
Why?
|
| Microscopy, Confocal | 3 | 2012 | 663 | 0.110 |
Why?
|
| Toxicity Tests | 1 | 2013 | 50 | 0.110 |
Why?
|
| Membrane Potential, Mitochondrial | 1 | 2013 | 133 | 0.110 |
Why?
|
| Microscopy, Polarization | 1 | 2012 | 9 | 0.110 |
Why?
|
| Basic Helix-Loop-Helix Transcription Factors | 1 | 2017 | 622 | 0.110 |
Why?
|
| Oocyte Retrieval | 1 | 2012 | 10 | 0.110 |
Why?
|
| Light | 4 | 2003 | 245 | 0.110 |
Why?
|
| Sperm Retrieval | 1 | 2012 | 10 | 0.110 |
Why?
|
| Drug Resistance | 2 | 2011 | 587 | 0.110 |
Why?
|
| Transcription Factors | 3 | 2015 | 5270 | 0.110 |
Why?
|
| Genotype | 2 | 2019 | 4109 | 0.110 |
Why?
|
| Microspectrophotometry | 1 | 2012 | 2 | 0.110 |
Why?
|
| Lipid Peroxidation | 1 | 2013 | 157 | 0.110 |
Why?
|
| Aromatase | 1 | 2012 | 56 | 0.110 |
Why?
|
| Urogenital Neoplasms | 1 | 2013 | 108 | 0.110 |
Why?
|
| Biomedical Technology | 1 | 2013 | 35 | 0.110 |
Why?
|
| Receptors, CXCR4 | 1 | 2014 | 269 | 0.110 |
Why?
|
| Mast Cells | 1 | 2014 | 223 | 0.110 |
Why?
|
| Chromosomal Proteins, Non-Histone | 1 | 2015 | 362 | 0.110 |
Why?
|
| Research Design | 1 | 2020 | 1544 | 0.110 |
Why?
|
| Nanostructures | 1 | 2013 | 94 | 0.110 |
Why?
|
| Hydroxamic Acids | 1 | 2015 | 442 | 0.110 |
Why?
|
| Retrospective Studies | 5 | 2023 | 37905 | 0.100 |
Why?
|
| Rodenticides | 1 | 2011 | 2 | 0.100 |
Why?
|
| 4-Hydroxycoumarins | 1 | 2011 | 2 | 0.100 |
Why?
|
| Child | 7 | 2024 | 29154 | 0.100 |
Why?
|
| Endangered Species | 1 | 2011 | 11 | 0.100 |
Why?
|
| Gonadotropins, Pituitary | 1 | 1991 | 8 | 0.100 |
Why?
|
| Lasers | 1 | 2012 | 198 | 0.100 |
Why?
|
| Infertility | 1 | 2013 | 123 | 0.100 |
Why?
|
| Antineoplastic Agents, Alkylating | 2 | 2014 | 588 | 0.100 |
Why?
|
| Vitamin K | 1 | 2011 | 54 | 0.100 |
Why?
|
| Gene Expression Profiling | 6 | 2022 | 5159 | 0.100 |
Why?
|
| Neoplasms | 5 | 2011 | 15193 | 0.100 |
Why?
|
| Cryoprotective Agents | 1 | 2011 | 11 | 0.100 |
Why?
|
| In Vitro Techniques | 3 | 2018 | 1618 | 0.100 |
Why?
|
| Vagina | 1 | 1993 | 317 | 0.100 |
Why?
|
| Lateral Ventricles | 1 | 2010 | 26 | 0.100 |
Why?
|
| Proteomics | 3 | 2019 | 1380 | 0.100 |
Why?
|
| Neoplasm Seeding | 1 | 2011 | 66 | 0.100 |
Why?
|
| Cell Cycle Proteins | 2 | 2017 | 2045 | 0.100 |
Why?
|
| Middle Aged | 13 | 2021 | 86204 | 0.100 |
Why?
|
| Receptors, FSH | 2 | 2003 | 21 | 0.090 |
Why?
|
| Interleukin-6 | 2 | 2005 | 1038 | 0.090 |
Why?
|
| Biological Evolution | 2 | 2016 | 278 | 0.090 |
Why?
|
| Endocrine System | 1 | 2010 | 36 | 0.090 |
Why?
|
| Dentate Gyrus | 1 | 2010 | 52 | 0.090 |
Why?
|
| Lipopolysaccharides | 3 | 2002 | 558 | 0.090 |
Why?
|
| Young Adult | 4 | 2019 | 21445 | 0.090 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2016 | 1439 | 0.090 |
Why?
|
| Aged | 10 | 2021 | 70117 | 0.090 |
Why?
|
| Tissue Engineering | 2 | 2013 | 269 | 0.090 |
Why?
|
| Histocytochemistry | 1 | 2009 | 185 | 0.090 |
Why?
|
| Cohort Studies | 1 | 2022 | 9244 | 0.090 |
Why?
|
| Magnetics | 1 | 2009 | 107 | 0.090 |
Why?
|
| Adolescent | 4 | 2019 | 31252 | 0.090 |
Why?
|
| Hormones | 3 | 2021 | 266 | 0.090 |
Why?
|
| Testicular Neoplasms | 2 | 2012 | 529 | 0.090 |
Why?
|
| Multipotent Stem Cells | 1 | 2009 | 52 | 0.090 |
Why?
|
| Reagent Kits, Diagnostic | 1 | 2009 | 70 | 0.090 |
Why?
|
| Microscopy, Fluorescence | 2 | 2014 | 769 | 0.090 |
Why?
|
| Transplantation, Autologous | 2 | 2005 | 1914 | 0.090 |
Why?
|
| Activins | 3 | 2000 | 98 | 0.080 |
Why?
|
| Germany | 2 | 2021 | 111 | 0.080 |
Why?
|
| Chromosomes, Human | 1 | 2010 | 295 | 0.080 |
Why?
|
| Stage-Specific Embryonic Antigens | 1 | 2008 | 7 | 0.080 |
Why?
|
| Receptors, Cell Surface | 2 | 2021 | 862 | 0.080 |
Why?
|
| Blood-Testis Barrier | 1 | 2008 | 6 | 0.080 |
Why?
|
| Cell Aggregation | 1 | 2008 | 61 | 0.080 |
Why?
|
| Azacitidine | 1 | 2015 | 1149 | 0.080 |
Why?
|
| DNA (Cytosine-5-)-Methyltransferases | 1 | 2011 | 310 | 0.080 |
Why?
|
| Rats, Inbred Strains | 1 | 2008 | 410 | 0.080 |
Why?
|
| Tight Junctions | 1 | 2008 | 56 | 0.080 |
Why?
|
| Neurogenesis | 1 | 2010 | 238 | 0.080 |
Why?
|
| Organ Preservation | 1 | 2008 | 43 | 0.080 |
Why?
|
| Androgen Antagonists | 2 | 2015 | 411 | 0.080 |
Why?
|
| Tyrphostins | 1 | 2008 | 107 | 0.080 |
Why?
|
| Tissue Embedding | 1 | 2008 | 28 | 0.080 |
Why?
|
| Carboplatin | 1 | 2011 | 823 | 0.080 |
Why?
|
| Pulsatile Flow | 1 | 2008 | 131 | 0.080 |
Why?
|
| Neovascularization, Physiologic | 1 | 2010 | 345 | 0.080 |
Why?
|
| Contraceptive Agents, Male | 2 | 2007 | 20 | 0.080 |
Why?
|
| Tissue Fixation | 1 | 2008 | 136 | 0.080 |
Why?
|
| Phosphorylation | 1 | 2015 | 4804 | 0.080 |
Why?
|
| Indenes | 1 | 2007 | 11 | 0.080 |
Why?
|
| Chromatography, Liquid | 2 | 2021 | 342 | 0.070 |
Why?
|
| Analysis of Variance | 3 | 2001 | 2307 | 0.070 |
Why?
|
| Recovery of Function | 2 | 2010 | 703 | 0.070 |
Why?
|
| Alkylating Agents | 1 | 2007 | 78 | 0.070 |
Why?
|
| Mice, Inbred BALB C | 2 | 2011 | 2314 | 0.070 |
Why?
|
| Dose-Response Relationship, Drug | 2 | 2019 | 4938 | 0.070 |
Why?
|
| Mitochondria | 1 | 2013 | 1282 | 0.070 |
Why?
|
| Injections, Intraperitoneal | 1 | 2006 | 197 | 0.070 |
Why?
|
| Ligands | 2 | 2021 | 995 | 0.070 |
Why?
|
| Dimethyl Sulfoxide | 2 | 2011 | 52 | 0.070 |
Why?
|
| Integrin alpha6 | 1 | 2005 | 17 | 0.070 |
Why?
|
| Radioimmunoassay | 4 | 2007 | 191 | 0.070 |
Why?
|
| Luteinizing Hormone, beta Subunit | 1 | 2005 | 3 | 0.070 |
Why?
|
| Follicle Stimulating Hormone, beta Subunit | 1 | 2005 | 9 | 0.070 |
Why?
|
| Aged, 80 and over | 4 | 2019 | 29902 | 0.070 |
Why?
|
| Flutamide | 1 | 2005 | 40 | 0.060 |
Why?
|
| Immunoenzyme Techniques | 3 | 2014 | 1165 | 0.060 |
Why?
|
| Octamer Transcription Factor-3 | 1 | 2005 | 107 | 0.060 |
Why?
|
| Rodentia | 1 | 2005 | 65 | 0.060 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 3 | 2018 | 2508 | 0.060 |
Why?
|
| Sequence Analysis, RNA | 2 | 2019 | 651 | 0.060 |
Why?
|
| Epigenesis, Genetic | 3 | 2019 | 1399 | 0.060 |
Why?
|
| Mice, Inbred Strains | 1 | 2005 | 521 | 0.060 |
Why?
|
| Skin | 2 | 2017 | 1259 | 0.060 |
Why?
|
| Random Allocation | 1 | 2006 | 703 | 0.060 |
Why?
|
| Receptors, Androgen | 2 | 2003 | 878 | 0.060 |
Why?
|
| Antimetabolites | 1 | 2004 | 69 | 0.060 |
Why?
|
| Odontogenesis | 1 | 2003 | 2 | 0.060 |
Why?
|
| Recombinant Proteins | 2 | 2012 | 2927 | 0.060 |
Why?
|
| Tooth | 1 | 2003 | 14 | 0.060 |
Why?
|
| Urodela | 1 | 2003 | 17 | 0.060 |
Why?
|
| Mass Spectrometry | 2 | 2018 | 702 | 0.060 |
Why?
|
| Leukemia, Myeloid, Acute | 1 | 2024 | 6915 | 0.060 |
Why?
|
| Fertilization | 1 | 2024 | 56 | 0.060 |
Why?
|
| Cyclophosphamide | 1 | 2011 | 3001 | 0.060 |
Why?
|
| Men's Health | 1 | 2023 | 19 | 0.060 |
Why?
|
| Cell Transplantation | 1 | 2003 | 85 | 0.060 |
Why?
|
| Risk Factors | 2 | 2019 | 17523 | 0.060 |
Why?
|
| Estradiol Congeners | 1 | 2003 | 8 | 0.060 |
Why?
|
| Ethinyl Estradiol | 1 | 2003 | 15 | 0.060 |
Why?
|
| Nitric Oxide Synthase | 2 | 2002 | 314 | 0.060 |
Why?
|
| Hair | 1 | 2003 | 42 | 0.060 |
Why?
|
| Estrogens, Non-Steroidal | 1 | 2003 | 44 | 0.060 |
Why?
|
| Radiation Dosage | 1 | 2007 | 1014 | 0.050 |
Why?
|
| Biomedical Research | 1 | 2010 | 806 | 0.050 |
Why?
|
| Proto-Oncogene Proteins | 2 | 2019 | 2488 | 0.050 |
Why?
|
| Calcium Channels | 1 | 2024 | 197 | 0.050 |
Why?
|
| Totipotent Stem Cells | 1 | 2002 | 2 | 0.050 |
Why?
|
| Estrogens | 2 | 2015 | 751 | 0.050 |
Why?
|
| Peer Review | 1 | 2022 | 80 | 0.050 |
Why?
|
| Phenols | 1 | 2003 | 107 | 0.050 |
Why?
|
| Morbidity | 1 | 2023 | 397 | 0.050 |
Why?
|
| Nucleotides | 1 | 2022 | 164 | 0.050 |
Why?
|
| Mutagenesis | 1 | 2003 | 483 | 0.050 |
Why?
|
| Early Growth Response Transcription Factors | 1 | 2021 | 2 | 0.050 |
Why?
|
| Eye Proteins | 2 | 2016 | 269 | 0.050 |
Why?
|
| Depression, Chemical | 1 | 2001 | 52 | 0.050 |
Why?
|
| Piperidines | 1 | 2007 | 1035 | 0.050 |
Why?
|
| Base Sequence | 5 | 2008 | 4917 | 0.050 |
Why?
|
| Basement Membrane | 2 | 2018 | 138 | 0.050 |
Why?
|
| Transplantation, Homologous | 2 | 2011 | 2843 | 0.050 |
Why?
|
| Sex Characteristics | 1 | 2003 | 417 | 0.050 |
Why?
|
| RNA Splicing | 1 | 2022 | 370 | 0.050 |
Why?
|
| Membrane Glycoproteins | 1 | 2005 | 1073 | 0.050 |
Why?
|
| Homozygote | 1 | 2022 | 717 | 0.050 |
Why?
|
| Amanitins | 1 | 2019 | 5 | 0.050 |
Why?
|
| Preoperative Period | 1 | 2021 | 344 | 0.050 |
Why?
|
| Agar | 2 | 2011 | 26 | 0.050 |
Why?
|
| Antigens, CD | 1 | 2005 | 1385 | 0.050 |
Why?
|
| Publishing | 1 | 2022 | 220 | 0.050 |
Why?
|
| Nucleic Acid Synthesis Inhibitors | 1 | 2019 | 43 | 0.050 |
Why?
|
| Cercopithecidae | 1 | 1999 | 10 | 0.050 |
Why?
|
| COP9 Signalosome Complex | 1 | 2019 | 72 | 0.040 |
Why?
|
| Antigens, Neoplasm | 2 | 2019 | 1506 | 0.040 |
Why?
|
| Neurons | 1 | 2010 | 2287 | 0.040 |
Why?
|
| Endotoxins | 1 | 2000 | 96 | 0.040 |
Why?
|
| DNA Primers | 3 | 2008 | 1399 | 0.040 |
Why?
|
| Steroids | 1 | 2021 | 356 | 0.040 |
Why?
|
| Y Chromosome | 1 | 1999 | 77 | 0.040 |
Why?
|
| World Health Organization | 1 | 2021 | 316 | 0.040 |
Why?
|
| Heme Oxygenase (Decyclizing) | 1 | 2019 | 19 | 0.040 |
Why?
|
| Receptor Protein-Tyrosine Kinases | 1 | 2004 | 661 | 0.040 |
Why?
|
| Monkey Diseases | 1 | 1999 | 50 | 0.040 |
Why?
|
| NADPH Oxidase 4 | 1 | 2019 | 23 | 0.040 |
Why?
|
| Geriatric Assessment | 1 | 2021 | 275 | 0.040 |
Why?
|
| Cell Movement | 3 | 2013 | 2466 | 0.040 |
Why?
|
| Cell Shape | 1 | 2019 | 128 | 0.040 |
Why?
|
| Microinjections | 1 | 1999 | 96 | 0.040 |
Why?
|
| DNA-Binding Proteins | 1 | 2012 | 4821 | 0.040 |
Why?
|
| Forecasting | 1 | 2002 | 694 | 0.040 |
Why?
|
| Reference Values | 1 | 2021 | 1099 | 0.040 |
Why?
|
| Symptom Assessment | 1 | 2021 | 267 | 0.040 |
Why?
|
| Sus scrofa | 1 | 2019 | 169 | 0.040 |
Why?
|
| Angiostatic Proteins | 1 | 2018 | 1 | 0.040 |
Why?
|
| Kinetics | 1 | 2002 | 2049 | 0.040 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 2 | 2016 | 1489 | 0.040 |
Why?
|
| Paraffin Embedding | 1 | 2019 | 226 | 0.040 |
Why?
|
| Mice, Knockout | 2 | 2019 | 5710 | 0.040 |
Why?
|
| Transcriptome | 2 | 2017 | 1859 | 0.040 |
Why?
|
| Neurotoxicity Syndromes | 1 | 2019 | 113 | 0.040 |
Why?
|
| Gene Duplication | 2 | 2016 | 421 | 0.040 |
Why?
|
| Injections | 1 | 1999 | 285 | 0.040 |
Why?
|
| Transcription, Genetic | 2 | 2021 | 3154 | 0.040 |
Why?
|
| Cyproterone Acetate | 1 | 2017 | 7 | 0.040 |
Why?
|
| Zygote | 1 | 2017 | 36 | 0.040 |
Why?
|
| Hormone Antagonists | 1 | 1998 | 101 | 0.040 |
Why?
|
| Fibronectins | 1 | 1998 | 197 | 0.040 |
Why?
|
| Blotting, Western | 2 | 2016 | 3536 | 0.040 |
Why?
|
| Fluorescent Antibody Technique | 2 | 2011 | 1062 | 0.040 |
Why?
|
| Epithelial Cells | 1 | 2005 | 1818 | 0.040 |
Why?
|
| Membrane Proteins | 1 | 2008 | 2819 | 0.040 |
Why?
|
| Radiotherapy | 2 | 2002 | 1824 | 0.040 |
Why?
|
| Cell Cycle | 1 | 2023 | 2084 | 0.040 |
Why?
|
| Gene Regulatory Networks | 1 | 2021 | 677 | 0.040 |
Why?
|
| Radiation Injuries | 1 | 2005 | 1411 | 0.040 |
Why?
|
| Corneal Keratocytes | 1 | 2016 | 5 | 0.040 |
Why?
|
| Twins, Monozygotic | 1 | 2017 | 129 | 0.040 |
Why?
|
| Molecular Chaperones | 1 | 2018 | 264 | 0.040 |
Why?
|
| HLA-G Antigens | 1 | 2016 | 17 | 0.040 |
Why?
|
| Keratoplasty, Penetrating | 1 | 2016 | 48 | 0.040 |
Why?
|
| Epidemiologic Studies | 1 | 2016 | 60 | 0.040 |
Why?
|
| Growth Substances | 1 | 1997 | 300 | 0.040 |
Why?
|
| Thyrotropin | 1 | 2016 | 119 | 0.040 |
Why?
|
| Receptors, Thyroid Hormone | 1 | 2016 | 93 | 0.040 |
Why?
|
| Extracellular Matrix Proteins | 1 | 1998 | 315 | 0.040 |
Why?
|
| Capillaries | 1 | 2016 | 99 | 0.040 |
Why?
|
| Congenital Abnormalities | 1 | 2019 | 260 | 0.040 |
Why?
|
| Alu Elements | 1 | 2016 | 88 | 0.040 |
Why?
|
| Glycoproteins | 1 | 2000 | 747 | 0.040 |
Why?
|
| Hypothyroidism | 1 | 1998 | 204 | 0.030 |
Why?
|
| Surveys and Questionnaires | 2 | 2021 | 5687 | 0.030 |
Why?
|
| 3-Hydroxysteroid Dehydrogenases | 1 | 1995 | 7 | 0.030 |
Why?
|
| Glial Fibrillary Acidic Protein | 1 | 2016 | 151 | 0.030 |
Why?
|
| Gamma Rays | 1 | 2017 | 242 | 0.030 |
Why?
|
| Homeodomain Proteins | 1 | 2021 | 1143 | 0.030 |
Why?
|
| Bone Marrow | 1 | 2024 | 2358 | 0.030 |
Why?
|
| Proto-Oncogene Proteins c-mdm2 | 1 | 2019 | 507 | 0.030 |
Why?
|
| S Phase | 1 | 1996 | 281 | 0.030 |
Why?
|
| Hemizygote | 1 | 2015 | 17 | 0.030 |
Why?
|
| DNA Copy Number Variations | 1 | 2022 | 1516 | 0.030 |
Why?
|
| Up-Regulation | 2 | 2018 | 2450 | 0.030 |
Why?
|
| Calcium-Binding Proteins | 1 | 1998 | 545 | 0.030 |
Why?
|
| Ethics, Medical | 1 | 1999 | 442 | 0.030 |
Why?
|
| Cell Death | 1 | 2017 | 671 | 0.030 |
Why?
|
| Genetic Diseases, Inborn | 1 | 2019 | 442 | 0.030 |
Why?
|
| Acetates | 1 | 1995 | 105 | 0.030 |
Why?
|
| Aldehyde Oxidoreductases | 1 | 2014 | 34 | 0.030 |
Why?
|
| Mutation | 1 | 2015 | 15179 | 0.030 |
Why?
|
| Tears | 1 | 2016 | 181 | 0.030 |
Why?
|
| Retinal Dehydrogenase | 1 | 2014 | 91 | 0.030 |
Why?
|
| Octamer Transcription Factors | 1 | 2014 | 19 | 0.030 |
Why?
|
| Endocrine Disruptors | 1 | 2015 | 53 | 0.030 |
Why?
|
| Tryptases | 1 | 2014 | 48 | 0.030 |
Why?
|
| Nucleic Acid Hybridization | 1 | 2015 | 542 | 0.030 |
Why?
|
| Genetic Loci | 1 | 2016 | 481 | 0.030 |
Why?
|
| Immunity | 1 | 2016 | 342 | 0.030 |
Why?
|
| Evaluation Studies as Topic | 1 | 1994 | 418 | 0.030 |
Why?
|
| Phylogeny | 1 | 2016 | 826 | 0.030 |
Why?
|
| Kidney Diseases | 1 | 2019 | 691 | 0.030 |
Why?
|
| Tissue Distribution | 1 | 1995 | 875 | 0.030 |
Why?
|
| Pregnancy, Animal | 1 | 2013 | 92 | 0.030 |
Why?
|
| Postoperative Care | 1 | 2017 | 739 | 0.030 |
Why?
|
| Receptors, LHRH | 1 | 2013 | 41 | 0.030 |
Why?
|
| Body Mass Index | 1 | 2021 | 2203 | 0.030 |
Why?
|
| Cartilage | 1 | 2013 | 128 | 0.030 |
Why?
|
| Liver | 2 | 2013 | 2961 | 0.030 |
Why?
|
| Cellular Senescence | 1 | 1995 | 382 | 0.030 |
Why?
|
| Blotting, Northern | 3 | 2000 | 682 | 0.030 |
Why?
|
| Organogenesis | 1 | 2013 | 119 | 0.030 |
Why?
|
| Biomarkers, Tumor | 1 | 2012 | 10331 | 0.030 |
Why?
|
| Ploidies | 1 | 2013 | 248 | 0.030 |
Why?
|
| Hematopoietic Stem Cell Transplantation | 1 | 2011 | 6550 | 0.030 |
Why?
|
| Spectroscopy, Fourier Transform Infrared | 1 | 2012 | 34 | 0.030 |
Why?
|
| Culture Media, Conditioned | 1 | 2013 | 260 | 0.030 |
Why?
|
| Molecular Sequence Data | 3 | 2008 | 6089 | 0.030 |
Why?
|
| Pregnancy Rate | 1 | 2012 | 58 | 0.030 |
Why?
|
| Felidae | 1 | 2011 | 1 | 0.030 |
Why?
|
| Tretinoin | 1 | 2014 | 623 | 0.030 |
Why?
|
| Rodent Control | 1 | 2011 | 1 | 0.030 |
Why?
|
| Gene Deletion | 1 | 1997 | 1442 | 0.030 |
Why?
|
| Epithelium | 1 | 1994 | 720 | 0.030 |
Why?
|
| Vitamin K Epoxide Reductases | 1 | 2011 | 7 | 0.030 |
Why?
|
| Corpus Striatum | 1 | 2012 | 104 | 0.030 |
Why?
|
| Hydrogen Peroxide | 1 | 2012 | 217 | 0.030 |
Why?
|
| Mixed Function Oxygenases | 1 | 2011 | 64 | 0.030 |
Why?
|
| RNA, Small Interfering | 1 | 2018 | 2216 | 0.030 |
Why?
|
| SOXB1 Transcription Factors | 1 | 2012 | 123 | 0.030 |
Why?
|
| Ethylene Glycol | 1 | 2011 | 5 | 0.020 |
Why?
|
| Propylene Glycol | 1 | 2011 | 10 | 0.020 |
Why?
|
| Disease Models, Animal | 2 | 2016 | 7222 | 0.020 |
Why?
|
| Neoplasms, Germ Cell and Embryonal | 1 | 2014 | 328 | 0.020 |
Why?
|
| Cell Line | 1 | 2019 | 5114 | 0.020 |
Why?
|
| Cross-Sectional Studies | 1 | 2021 | 4314 | 0.020 |
Why?
|
| Tissue Transplantation | 1 | 2010 | 35 | 0.020 |
Why?
|
| Autoradiography | 1 | 2010 | 132 | 0.020 |
Why?
|
| Administration, Oral | 2 | 2007 | 1544 | 0.020 |
Why?
|
| Oligopeptides | 1 | 2013 | 429 | 0.020 |
Why?
|
| Polymorphism, Genetic | 1 | 2016 | 1450 | 0.020 |
Why?
|
| Chromatography, High Pressure Liquid | 1 | 1992 | 548 | 0.020 |
Why?
|
| Genetic Markers | 1 | 2013 | 974 | 0.020 |
Why?
|
| Nitric Oxide Synthase Type II | 2 | 2002 | 261 | 0.020 |
Why?
|
| Oxidation-Reduction | 1 | 2012 | 717 | 0.020 |
Why?
|
| Infant, Newborn | 1 | 2023 | 8223 | 0.020 |
Why?
|
| Blood Coagulation | 1 | 2011 | 185 | 0.020 |
Why?
|
| Rats, Transgenic | 1 | 2010 | 21 | 0.020 |
Why?
|
| Cytosine | 1 | 2011 | 141 | 0.020 |
Why?
|
| High-Throughput Nucleotide Sequencing | 1 | 2019 | 2291 | 0.020 |
Why?
|
| Bone and Bones | 1 | 2013 | 619 | 0.020 |
Why?
|
| Alleles | 1 | 2016 | 2437 | 0.020 |
Why?
|
| Protein Conformation | 1 | 1993 | 1258 | 0.020 |
Why?
|
| In Situ Hybridization | 2 | 2003 | 1037 | 0.020 |
Why?
|
| Chi-Square Distribution | 1 | 2012 | 1323 | 0.020 |
Why?
|
| Linear Models | 1 | 2012 | 1085 | 0.020 |
Why?
|
| Neural Stem Cells | 1 | 2010 | 181 | 0.020 |
Why?
|
| Iron | 1 | 2012 | 376 | 0.020 |
Why?
|
| Regression Analysis | 1 | 2012 | 1546 | 0.020 |
Why?
|
| Infertility, Female | 1 | 2011 | 217 | 0.020 |
Why?
|
| Choice Behavior | 1 | 2011 | 226 | 0.020 |
Why?
|
| Junctional Adhesion Molecules | 1 | 2008 | 2 | 0.020 |
Why?
|
| Claudin-3 | 1 | 2008 | 7 | 0.020 |
Why?
|
| Isoenzymes | 1 | 2011 | 614 | 0.020 |
Why?
|
| Occludin | 1 | 2008 | 31 | 0.020 |
Why?
|
| Sequence Analysis, DNA | 1 | 2016 | 2483 | 0.020 |
Why?
|
| Zonula Occludens-1 Protein | 1 | 2008 | 30 | 0.020 |
Why?
|
| Prevalence | 1 | 2016 | 3260 | 0.020 |
Why?
|
| Fetus | 1 | 2012 | 601 | 0.020 |
Why?
|
| Claudins | 1 | 2008 | 47 | 0.020 |
Why?
|
| GAP-43 Protein | 1 | 2008 | 13 | 0.020 |
Why?
|
| Cell Line, Tumor | 2 | 2015 | 14551 | 0.020 |
Why?
|
| Integrin alpha Chains | 1 | 2008 | 28 | 0.020 |
Why?
|
| Infant | 1 | 2023 | 13310 | 0.020 |
Why?
|
| Tissue and Organ Procurement | 1 | 2011 | 233 | 0.020 |
Why?
|
| Green Fluorescent Proteins | 1 | 2010 | 694 | 0.020 |
Why?
|
| Electrophoresis, Gel, Two-Dimensional | 1 | 2008 | 212 | 0.020 |
Why?
|
| Laminin | 1 | 2008 | 194 | 0.020 |
Why?
|
| Drug Implants | 1 | 2007 | 46 | 0.020 |
Why?
|
| Myocardium | 1 | 2013 | 1313 | 0.020 |
Why?
|
| Trans-Activators | 1 | 2013 | 1555 | 0.020 |
Why?
|
| Tumor Suppressor Protein p53 | 1 | 2019 | 3552 | 0.020 |
Why?
|
| Graft Rejection | 1 | 2011 | 834 | 0.020 |
Why?
|
| Tea Tree Oil | 1 | 2005 | 1 | 0.020 |
Why?
|
| Castor Oil | 1 | 2005 | 4 | 0.020 |
Why?
|
| Pharmaceutical Vehicles | 1 | 2005 | 15 | 0.020 |
Why?
|
| Follow-Up Studies | 1 | 2021 | 14889 | 0.020 |
Why?
|
| Fibroblasts | 1 | 2012 | 1682 | 0.020 |
Why?
|
| Organ Transplantation | 1 | 2008 | 191 | 0.020 |
Why?
|
| Mice, Inbred ICR | 1 | 2005 | 239 | 0.020 |
Why?
|
| Transplants | 1 | 2005 | 52 | 0.020 |
Why?
|
| Soybean Oil | 1 | 2005 | 66 | 0.020 |
Why?
|
| Cell Adhesion Molecules | 1 | 2008 | 577 | 0.020 |
Why?
|
| Growth Hormone | 1 | 2005 | 226 | 0.020 |
Why?
|
| Bioethics | 1 | 2006 | 70 | 0.020 |
Why?
|
| Drug Evaluation, Preclinical | 1 | 2007 | 503 | 0.020 |
Why?
|
| Injections, Intramuscular | 1 | 2005 | 255 | 0.020 |
Why?
|
| Ubiquitin Thiolesterase | 1 | 2005 | 216 | 0.020 |
Why?
|
| Tooth Germ | 1 | 2003 | 4 | 0.020 |
Why?
|
| Dentition | 1 | 2003 | 7 | 0.020 |
Why?
|
| Ultrasonography | 1 | 2011 | 1863 | 0.010 |
Why?
|
| Mice, Inbred DBA | 1 | 2003 | 110 | 0.010 |
Why?
|
| Testosterone Congeners | 1 | 2003 | 26 | 0.010 |
Why?
|
| Predictive Value of Tests | 1 | 2012 | 4892 | 0.010 |
Why?
|
| Brain Chemistry | 1 | 2003 | 145 | 0.010 |
Why?
|
| Gametogenesis | 1 | 2003 | 28 | 0.010 |
Why?
|
| Embryonic and Fetal Development | 1 | 2003 | 205 | 0.010 |
Why?
|
| Phosphoproteins | 1 | 2008 | 1152 | 0.010 |
Why?
|
| Gene Targeting | 1 | 2003 | 292 | 0.010 |
Why?
|
| Receptor, Notch1 | 1 | 2004 | 218 | 0.010 |
Why?
|
| Benzhydryl Compounds | 1 | 2003 | 85 | 0.010 |
Why?
|
| Nuclear Proteins | 1 | 2013 | 3343 | 0.010 |
Why?
|
| Child, Preschool | 1 | 2018 | 16273 | 0.010 |
Why?
|
| Mosaicism | 1 | 2003 | 272 | 0.010 |
Why?
|
| Proto-Oncogene Proteins c-ret | 1 | 2004 | 370 | 0.010 |
Why?
|
| Dinoprostone | 1 | 2002 | 208 | 0.010 |
Why?
|
| Indicators and Reagents | 1 | 2000 | 128 | 0.010 |
Why?
|
| Treatment Outcome | 2 | 2012 | 32848 | 0.010 |
Why?
|
| Phenotype | 1 | 2012 | 6295 | 0.010 |
Why?
|
| Follistatin | 1 | 2000 | 55 | 0.010 |
Why?
|
| Deleted in Azoospermia 1 Protein | 1 | 1999 | 1 | 0.010 |
Why?
|
| Treatment Failure | 1 | 2003 | 1391 | 0.010 |
Why?
|
| Prostate | 1 | 2005 | 1088 | 0.010 |
Why?
|
| Pseudogenes | 1 | 1999 | 81 | 0.010 |
Why?
|
| Sequence Homology, Nucleic Acid | 1 | 1999 | 354 | 0.010 |
Why?
|
| In Situ Nick-End Labeling | 1 | 2000 | 448 | 0.010 |
Why?
|
| Microspheres | 1 | 1999 | 210 | 0.010 |
Why?
|
| Body Fluids | 1 | 2000 | 125 | 0.010 |
Why?
|
| Antithyroid Agents | 1 | 1998 | 9 | 0.010 |
Why?
|
| Fluorescent Antibody Technique, Direct | 1 | 1998 | 19 | 0.010 |
Why?
|
| Propylthiouracil | 1 | 1998 | 10 | 0.010 |
Why?
|
| Genes | 1 | 1999 | 491 | 0.010 |
Why?
|
| Pan troglodytes | 1 | 2000 | 207 | 0.010 |
Why?
|
| Rabbits | 1 | 1999 | 957 | 0.010 |
Why?
|
| DNA, Complementary | 1 | 1999 | 869 | 0.010 |
Why?
|
| Chromosomes, Human, Pair 3 | 1 | 1999 | 311 | 0.010 |
Why?
|
| Sequence Alignment | 1 | 1999 | 844 | 0.010 |
Why?
|
| Endothelium, Vascular | 1 | 2002 | 891 | 0.010 |
Why?
|
| Exons | 1 | 1999 | 1328 | 0.010 |
Why?
|
| Ribonucleases | 1 | 1995 | 88 | 0.010 |
Why?
|
| Immunoglobulin G | 1 | 1999 | 1021 | 0.010 |
Why?
|
| Evolution, Molecular | 1 | 1999 | 834 | 0.010 |
Why?
|
| Protein Biosynthesis | 1 | 1998 | 889 | 0.010 |
Why?
|
| Organ Specificity | 1 | 1995 | 699 | 0.010 |
Why?
|
| Databases, Factual | 1 | 2000 | 2218 | 0.010 |
Why?
|
| Escherichia coli | 1 | 2000 | 1203 | 0.010 |
Why?
|
| Dark Adaptation | 1 | 1992 | 27 | 0.010 |
Why?
|
| Hodgkin Disease | 1 | 2000 | 1429 | 0.010 |
Why?
|
| Leukemia | 1 | 2000 | 1635 | 0.010 |
Why?
|